login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
NUVATION BIO INC (NUVB) Stock News
USA
-
New York Stock Exchange
- NYSE:NUVB -
US67080N1019
-
Common Stock
8.43
USD
+0.16 (+1.93%)
Last: 12/12/2025, 8:04:00 PM
8.36
USD
-0.07 (-0.83%)
After Hours:
12/12/2025, 8:04:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NUVB Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Innovent Biologics
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
11 days ago - By: Nuvation Bio
Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology
17 days ago - By: Nuvation Bio
Nuvation Bio to Participate in Upcoming Investor Conferences
24 days ago - By: Stocktwits
Nuvation Bio Stock Logs Its Best Session Ever: Wall Street Turns Bullish On Lung Cancer Drug’s Blockbuster Debut
2 months ago - By: Benzinga
4 Analysts Assess Nuvation Bio: What You Need To Know
3 months ago - By: Benzinga
Analyst Expectations For Nuvation Bio's Future
a month ago - By: The Motley Fool
Nuvation Bio (NUVB) Q3 2025 Earnings Transcript
a month ago - By: Zacks Investment Research
- Mentions:
DVAX
Nuvation Bio Inc. (NUVB) Reports Q3 Loss, Tops Revenue Estimates
a month ago - By: Nuvation Bio Inc.
Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
a month ago - By: The Motley Fool
Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock
a month ago - By: Nuvation Bio
Nuvation Bio to Participate in Upcoming Investor Conferences
2 months ago - By: Zacks Investment Research
- Mentions:
MDXG
MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates
2 months ago - By: Nuvation Bio
Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma
2 months ago - By: Nuvation Bio
Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025
2 months ago - By: New York Stock Exchange
- Mentions:
ESRT
NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street
2 months ago - By: Nuvation Bio
Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI™ (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer
3 months ago - By: Nuvation Bio
Nuvation Bio Receives Approval from Japan’s Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer
3 months ago - By: Nuvation Bio
Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer
4 months ago - By: Nuvation Bio
Nuvation Bio to Participate in Upcoming Investor Conferences
4 months ago - By: Zacks Investment Research
Nuvation Bio Inc. (NUVB) Just Flashed Golden Cross Signal: Do You Buy?
4 months ago - By: Zacks Investment Research
- Mentions:
LCTX
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates
4 months ago - By: Nuvation Bio
Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
4 months ago - By: Zacks Investment Research
- Mentions:
ACAD
Acadia Pharmaceuticals (ACAD) Tops Q2 Earnings and Revenue Estimates
4 months ago - By: Nuvation Bio
Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses
5 months ago - By: Nuvation Bio
Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025
Please enable JavaScript to continue using this application.